Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

DocGo (DCGO) Shares Outstanding (Diluted Average) (2020 - 2025)

DocGo (DCGO) has 6 years of Shares Outstanding (Diluted Average) data on record, last reported at $99.4 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) fell 6.45% year-over-year to $99.4 million; the TTM value through Sep 2025 reached $99.4 million, down 6.45%, while the annual FY2024 figure was $109.4 million, 3.6% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $99.4 million in Q3 2025 per DCGO's latest filing, up from $98.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $115.7 million in Q1 2022 and bottomed at $90505.0 in Q2 2021.
  • Average Shares Outstanding (Diluted Average) over 5 years is $96.1 million, with a median of $103.4 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): surged 127273.82% in 2022, then dropped 11.3% in 2023.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $94.9 million in 2021, then grew by 8.55% to $103.0 million in 2022, then rose by 2.57% to $105.6 million in 2023, then increased by 3.6% to $109.4 million in 2024, then decreased by 9.13% to $99.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $99.4 million in Q3 2025, $98.9 million in Q2 2025, and $101.6 million in Q1 2025.